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Background: Cancer registries help to decrease the burden of cancers by collecting accurate and complete data.
We aimed to measure the completeness of coverage of information recorded between 2000 and 2009 in a cancer
registry program in Fars province, southern Iran.
Methods: The cancer registry program run by Shiraz University of Medical Sciences was investigated in two
periods: pathology-based data from 2000 to 2007 and population-based data from 2007 to 2009. Completeness of
yearly coverage was measured as the number of reported cases of cancer in each year divided by estimated cases
based on 107.3 new cases per 100 000 individuals. The percentage of complete data registration (patient’s name,
age, gender, address, phone number and father’s name) and correct cancer encoding was calculated for each year
and compared to the maximum acceptable error rate for each item.
Results: A total of 29 277 non-duplicate cancer records were studied. Completeness of coverage varied from
22.68% in 2000 to 118.7% in 2008. Deficiencies in patients’ demographic data were highest for name in 2002
(0.09%), age in 2006 (2.36%), gender in 2001 (0.06%) and father’s name in 2001 (52.5%). Incomplete address (99.7%)
and missing phone number (100%) were most frequent in 2000, and deficiencies in encoding information were
highest in 2008 (6.36%).
Conclusions: The cancer registry program in Fars province (southern Iran) was considered satisfactory in terms of
completeness of coverage and information about age. However, it was deficient in recording patients’ phone
number and address, and father’s name. The error level for cancer encoding was unacceptably high. Enhancing
hardware and software resources, education and motivation in all public and private sectors involved in the cancer
registry program, and greater attention to epidemiological research are needed to increase the quality of the
cancer registry program, including its completeness.
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Cancer, which accounted for 13% of all global deaths in
2008, is predicted to become an increasingly important
cause of morbidity and mortality in the next few decades in
all regions of the world. The estimated percentage increase
in cancer incidence by 2030 (21.4 million, including 13.1
million deaths) compared to 2008 (12.7 million, including
7.6 million deaths) will be greater in low- (82%) and
lower-middle-income countries (70%) than in upper-middle
- (58%) and high-income countries (40%) [1].
Iran, with a population of approximately 74 million,
has an age-standardized death rate from cancer of 112.7
per 100 000 for males and 69.8 per 100 000 for females
[1]. Cancer is the third leading cause of death in this
country, [2] and accounted for 12% of all deaths [1] and
30 000 deaths among all ages in 2008 [2]. Moreover, it is
estimated that more than 70 000 new cases of cancer
occur in Iran annually [2]. In Fars province (southern
Iran) the cancer-related age-standardized death rate in
1998–2002 was 64.5 per 100 000 for men and 55.5 per
100 000 for women [3].
Cancer registries, which originated in the first half of
the twentieth century, have expanded in the last 20 years
[4] and have become the main source of epidemiological
information for all sectors involved in fighting cancer at
the local to international level [5]. These registries
systematically collect information about cancer burden by
recording the incidence, prevalence, mortality and survival
for different cancers [5,6]. Their role has expanded into the
planning and evaluation of cancer treatments and screening
programs, public health planning and patient care improve-
ment [4,7-10]. The etiology, biology and impact of interven-
tions to control cancers can also be studied through a
variety of epidemiologic methods with data from cancer
registries [8,11]. Projections about future needs for material
and manpower resources can be made on the basis of data
collected by registries [8].
The most comprehensive morbidity data for cancer
are available from population- or hospital-based cancer
registries, [1] but only population-based cancer registries
can provide an unbiased description of cancer profiles in
different populations [1]. However, only 36% of all countries
have a national population-based registry [1].
The cancer registry system managed by Shiraz University
of Medical Sciences was initially pathology-based from
2000 to 2007. Since 2007, the cancer registry system has
become population-based. The system collects data on
cancer cases from both hospital and nonhospital resources
in a confidential manner. In its more than 10 years of
operation, the registry has undergone qualitative and
quantitative changes in the staff who collect the data,
the centers reporting cancer cases and the software.
A crucial factor concerning the utility of cancer registries
is data quality in terms of comparability, validity, timelinessand completeness [12,13]. The comparability of cancer data
can be established through a comprehensive review of the
registration procedures. Validity can be examined with
numerical indices that permit comparisons across
time with other registries or within a registry, or
comparisons of specified subsets of cases. At present there
are no international guidelines for timeliness, although
some organizations have proposed specific standards for
the abstraction and reporting of registries [12]. The com-
pleteness of cancer registry data, i.e. the extent to which all
of the incident cancers occurring in the population are
included in the registry database, is an extremely important
attribute of a cancer registry. Only a high degree of com-
pleteness in case-finding procedures will ensure that cancer
incidence rates and survival proportions are close to their
true value [14]. The complete coverage of all cases is the
key criterion for data quality [9].
Objectives
This study was designed to document and evaluate the
10-year trends in completeness of coverage and complete-
ness of recorded demographic data and encoding informa-
tion in the Fars province cancer registry program. Our
ultimate aim was to detect possible deficiencies and suggest
the interventions needed to overcome them.
Methods
The data source for this cross-sectional study was all
cancer-related data recorded from 2000 to 2009 at a cancer
surveillance center affiliated with Shiraz University Medical
Sciences, southern Iran. To determine completeness of
coverage per year, the number of new cancers was divided
by the expected number of total cancers in that year in the
target population. The expected incidence rate of cancer
(excluding non-melanoma skin cancers) for Iran was
estimated by the World Health Organization as 107.3 cases
per 100 000 individuals [15]. The 10-year trend for
completeness of coverage was determined from the actual
registry data and compared the expected incidence rate.
To measure completeness of the data in the cancer
registry, the percentage rate of deficiencies in identity
(first name, last name and father’s name), demographic
information (gender, age and area of residence) and
encoding were calculated separately for each year and
then compared to other years as well as to the maximum
acceptable error rate established in the guidelines of the
cancer registry program for each item. The maximum
acceptable error rate was 5% for deficiencies in father’s
name, demographic information and cancer encoding.
The maximum acceptable error rate was 0.5% for
deficiencies in first name, last name and gender. The
data were entered into a Microsoft Office Excel 2007
spreadsheet and used to generate bar and linear
graphs with this software.
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of the study from extraction of the data from the
cancer registry to analysis, reporting and preserving
the backup data. The Ethics Committee of the Health
Policy Research Center affiliated with Shiraz University of
Medical Sciences approved this study on the basis of the
protocol described above.
Results
A total of 29 277 nonduplicate cancer records were
studied. Figure 1 shows that the number of cancer cases
increased from 866 in 2000 to 4926 in 2009. Completeness
of coverage also showed an overall increase from 22.68% in
2000 to a maximum of 118.7% in 2008. However, there was
a decrease of about 11.5% in 2003 and a decrease of about
1.5% in 2004 compared to 2002, and a small decrease of
0.3% in 2009 compared to 2008 (Figure 2).
The rate of deficiencies in the first and last name
showed a heterogeneous pattern. There were no deficien-
cies in 2000, 2003, 2004, 2007, 2008 and 2009. The rate of
deficiencies was 0.06% in 2001, 0.09% in 2002, 0.03% in
2005 and 0.02% in 2006 (Figure 3). The trend in incomplete
information about gender was also heterogeneous, with no
deficiencies in 2000, 2003, 2004, 2005, 2007, 2008 and
2009, but rates of 0.06% in 2001, 0.04% in 2002 and 0.02%
in 2006 (Figure 3). All of the deficiency rates in name or
gender information were below the acceptable error level
error of 0.5% (Figure 3).
The rates for incomplete data regarding patients’ age
showed little variation from 2000 to 2009. The error rateFigure 1 Number of reported and estimated cases of all cancers in 20was zero in 2000 and 2001 and highest in 2006 (2.36%);
however, even this highest rate was below the 5%
threshold for acceptable error rate (Figure 4).
Deficiencies in the father’s name were lowest in 2000
(3.34%) and highest in 2001 (52.5%). There was no
uniform pattern from 2001 to 2006, but thereafter
there was a downward trend until 2009. In all years
except 2000, the error rate was above acceptable 5%
limit; however, after 2006 the gap between real and
expected error rates became narrower, decreasing to
about 4% in 2009 (Figure 4).
Improvements in address information showed an
optimal trend, from only 0.3% complete data in 2000
to 93.69% in 2004. About 20% of address entries in
2005 and 30% in 2006 were incomplete. From 2006
to 2009 the difference between the real and maximum
acceptable error rate decreased; however, by the end
of the study period in 2009 the error rate (7.87%)
remained above the 5% threshold (Figure 4).
Of all variables analyzed here, phone numbers had the
highest error rates. In 2000 and 2001, phone numbers
were rarely recorded. In 2003 this information was
missing for about half of the patients in the registry,
and in 2004 and 2005 it was missing in about one-third of
the cases. As Figure 4 shows, this error rate showed a
downward trend between 2006 (44.97%) and 2009
(14.6%), but still remained above the acceptable 5% error
rate at the end of the study period.
The percentage rate of encoding errors was lowest in
2000 (1.27%) and was below 5% (acceptable error rate)00–2009 in Fars province, southern Iran.
Figure 2 Trend in completeness of data coverage in 2000–2009
in the cancer registry program in Fars province, southern Iran.
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errors surpassed the acceptable error rate in 2006 to
2009, although only by 0.64% in the final year of the
study period (5.64%) (Figure 4).
Discussion
Completeness of coverage of cancer-related data in the
cancer registry program in Fars province, southern Iran,
showed an increasing trend from 2000 to 2009, and was
above 100% during the last three years of the study
period. There are two possible explanations for the near-
100% coverage in the last three years of the study period.
One is the change in reporting resources from only
pathology centers between 2000 and 2007 to pathology-
and population-based resources from 2007 on. This
resulted in the capture of non pathology-based cases, i.e.
clinical reports and death records. The number of
reported cases (numerator) thus increased compared to
cases estimated on the basis of pathology-based casesFigure 3 Trend in incompleteness of data coverage for name and gen
province, southern Iran. The horizontal dotted axis shows the 0.5% level(denominator). The second explanation may be the actual
change in cancer incidence in Iran due to changes in life
style and predisposing factors, a process that necessitates
recalculation of the estimated numbers of cancer in
this country. However, these two possibilities will require
additional research to confirm.
Throughout the 10-year study period, data incom-
pleteness for name and gender of the patients in the
registry were far below the acceptable error rate of 0.5%,
and the error rate was zero during the last three years.
However, the data for phone number, address and
father’s name showed the highest rate of deficiencies,
which remained over the acceptable error rate of 5% in
all 10 years, with the exception of father’s name in 2000.
The gap between actual and acceptable error rates for
each item showed a decreasing trend toward 2009, when
the error rate was lowest. Encoding showed an incom-
pleteness rate around 5% between 2004 and 2009, but
remained above the 5% acceptable error rate from 2006
to 2009. Errors in age were below half of the acceptable
error rate of 5%, and were as low as 1% during the last
three years of the study period.
Improvements in the completeness of converge in
our regional cancer registry program may have
resulted from better communication with reporting
centers such as pathology laboratories and clinical
centers, which were sent directives and guidelines
regarding the registry as well as information regarding
the obligation to report cancer cases. Similar
improvements have also been seen in Iran’s national
cancer registry, which showed a remarkable increase
in completeness of coverage from 1999 (29%) to 2008
(92.85%) [16].der in 2000–2009 in the cancer registry program in Fars
of acceptable error.
Figure 4 Trend in incompleteness of data coverage for demographic, information, address and encoding in 2000–2009 in the cancer
registry program in Fars province, southern Iran. The horizontal dotted axis shows the 5% level of acceptable error.
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ness of registration of diagnosed cancer cases was 89.6%
(95% CI 87.0-91.7). Completeness varied with age (better
for patients less than 30 years old) and cancer site, and
cases with a histology report were more likely to be
registered than those without one [17]. A study in the
French Maritimes Alps district found that completeness
of their registry was 92.2% (95% CI: 91.5-93.0%) for breast
and colorectal cancer [18]. Overall completeness of a
cancer registry in Estonia was 90.8%, although the
rate varied by cancer site [19].
Completeness of reporting for ovarian cancer from one
health region in Norway during the 10-year period from
1987 to 1996 was 99.6% [20]. An evaluation of a cancer
registry program in Karachi, Pakistan showed a number of
defects at the beginning in 1995 but a marked increase in
completeness and accuracy of the data in 2000 [21].
In Fars province, reporting of the patient’s full name in
the cancer registry showed considerable improvement,
especially after 2007, as also occurred in the national regis-
try: the error rate was zero or close to zero in most years.
Therefore, deficiencies in this information remained negli-
gible. This finding shows that reporting centers have been
well informed about the importance of obtaining complete
information on each patient’s identity [16].
In the cancer registry analyzed here, the percentage of
deficiencies in gender-related data was quite small andconsistently below the threshold of acceptable error
throughout the study period.
The performance of the provincial registry we analyzed
in terms of completeness of age-related data improved
during the 10-year study period, and a similar pattern
was also reported for national registry [16]. Increasing
resources for case reporting during the period from
2000 to 2009 in our region, especially in last three years
of this period, resulted in more complete recording of
the father’s name in provincial registry, as was also
found for the national registry [16].
At the beginning of the registry program, the patients’
address was not recorded in detail in a systematic
manner. Although the rate of deficiencies decreased as a
result of staff training at reporting centers, the error rate
remained above our acceptable maximum level. This
finding confirms the need for planning in order to
improve the completeness of address-related information.
In the national cancer registry, errors in this item
decreased from 66.5% in 1999 to 21.4% in 2008 [16].
The completeness of information about cancer encoding
fluctuated throughout the study period. After 2007, when
the data were collected with both pathology and
population-based system, encoding errors and cases of
cancer of unknown origin and undefined codes have
become more frequent. However, Iran’s national level
cancer registry showed a decrease in encoding deficiencies
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reported a coding error rate of 2% [20].
Cancer registries need to ensure the quality of their
data. Earlier studies showed that stringent quality assurance
procedures can be used to achieve perfect accuracy, com-
pleteness, timeliness and confidentiality [20,22]. However,
these aims can only be achieved through planning, regulat-
ing, promoting and applying procedural rules, and by
supervising the correct implementation of quality assurance
measures. Such efforts in Iran, as in other Asian
countries, [23] are hampered by deficiencies in expertise
and resources, infrastructural weaknesses, and a lack of
epidemiology-based studies of case registry performance.
Because the burden of cancer is expected to increase,
strengthening the hardware and software resources needed
for cancer registry programs will play an essential role in
achieving and maintaining high standards in cancer case
registration. Increases in the number of trained staff
responsible for data collection will also be needed. As other
studies have emphasized, it is important to educate all
cancer registry data providers including pathology
departments as well as population-based centers, including
clinical centers and centers involved in the death registry
program, about the importance of reporting accurate,
timely and complete information [8,22,24].
The feedback provided by data registrars plays an
important role in efforts to improve the software used in
cancer registry programs. One indirect method to inves-
tigate data completeness is to measure indicators such
as the ratios of and overlap among cases based on clin-
ical and pathological reports and the death certificate
only [25]. However, the reporting system used for the
Fars province cancer registry program was pathology-
based until 2007, so these indicators could not be mea-
sured or compared for the years prior to 2007.
A source of potentially useful information in cancer
registries is data about the patient’s ethnicity. The
population of Fars province, like the population of
Iran, comprises several ethnicities, and data about the
distribution of cancers among these different groups
can be valuable for research on the etiological factors
involved in different types of cancer. A further way to
enhance the completeness and validity of the data in
such registries is to include ongoing research activities
regarding different aspects of cancer registry programs, as
suggested in an earlier Danish analysis [26].
Limitations
Our study had some limitations. We measured the com-
pleteness of data for all cancers as a whole. Different studies
have shown that this index can differ significantly among
cancers according to site [18,20] and age [18]. Furthermore,
we could not determine how much of the increase in
reported cancer cases after 2005 and especially after 2007was due to an actual increase in the cancer incidence in
our region, and how much was due to the change from
pathology centers only to both pathology-based and
population-based reporting systems.
Conclusions
In the cancer registry used in Fars province, southern
Iran, the completeness of coverage and information were
acceptable with regard to gender, first name, last name
and age. The error rates for these data were below the
maximum acceptable threshold. However, with regard to
father’s name and cancer encoding, the performance of
the registry failed to meet our standard for maximum
acceptable error rate. Currently about 25% of the pri-
mary data in the cancer registry is duplicated in any
given year, and considerable time is needed to match
and delete the repeated data, as is done annually in col-
laboration with the national cancer registry. Information
for the patients’ national identification number was also
inadequate. Improving the quality of the cancer registry
program in Iran will require funding for appropriate
infrastructure, enhanced hardware and software resources,
and increased expert staffing. Education and training are
needed for current staff, together with ways to encourage
and motivate public and private sectors of the cancer
registry program (e.g. physicians, pathology laboratories
and surgical services) to complete the cancer case registry
forms accurately and remit them to the appropriate
center in a timely fashion. Additional improvements
could be achieved by integrating ongoing research with
epidemiological studies in the cancer registry program.
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